The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Pharmaceutical And Life Sciences Real World Evidence Market In 2026, And How Will Its Value Evolve By 2030?
The market size for pharmaceutical and life sciences real world evidence has expanded considerably in recent years. It is projected to increase from $3.2 billion in 2025 to $3.57 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. Historically, this expansion has been driven by several factors, including the increasing uptake of electronic health records, a heightened focus on drug safety monitoring, the expansion of patient registries, a rising need for evidence-based decision making, and the growth in pharmaceutical R&D investments.
The pharmaceutical and life sciences real world evidence market is poised for significant expansion in the coming years, with its size projected to reach $5.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.9%. This growth throughout the forecast period is primarily driven by factors such as the incorporation of AI-powered analytics, the broadening scope of RWE platforms and dashboards, the adoption of tools for predictive modeling, increased collaboration between payers and pharmaceutical entities, and the expanding role of real-world evidence in personalized medicine. Key developments expected during this timeframe include the assimilation of diverse real-world data sources, the application of predictive modeling for drug outcome assessment, the creation of patient-centric evidence, the streamlining of regulatory compliance, and the utilization of sophisticated analytics for market entry strategies.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Shaping The Pharmaceutical And Life Sciences Real World Evidence Market Landscape?
The increasing need for individualized healthcare approaches is anticipated to fuel the expansion of the pharmaceutical and life sciences real-world evidence market in the future. Personalized medicine represents a method of tailoring healthcare and treatments specifically to a patient’s distinct biological and personal traits. The adoption of personalized medicine is rising because of breakthroughs in genomic technologies, which enable medical professionals to rapidly and precisely examine a patient’s genetic data, thereby facilitating more precise and impactful therapies. Within the pharmaceutical and life sciences sectors, real-world evidence supports personalized medicine through the analysis of actual patient information to ascertain the most efficacious and secure treatments for particular patient cohorts. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 new personalized treatments for rare disease patients, an increase from six in 2022. Among the recently approved personalized treatments for 2023 were also seven cancer drugs and three remedies for other illnesses and conditions. Consequently, the escalating demand for personalized medicine is propelling the expansion of the pharmaceutical and life sciences real-world evidence market.
Which Segment Types Are Examined In The Pharmaceutical And Life Sciences Real World Evidence Market Segment Study?
The pharmaceutical and life sciences real world evidence market covered in this report is segmented –
1) By Component: Services, Software, Data Sets
2) By Evidence: Descriptive Studies, Analytical Studies, Patient-Reported Outcomes
3) By Real-World Data Sources: Medical Claims, Clinical Trials, Clinical Setting, Patient Powered, Other Real-World Data Sources
4) By Application: Drug Discovery And Development Support, Regulatory Submission And Label Expansion, Market Access And Reimbursement Strategy, Drug Safety And Pharmacovigilance Monitoring, Treatment Decision Support And Clinical Optimization, Comparative Effectiveness And Outcomes Research
5) By End-User: Pharmaceutical And Biopharmaceutical Companies, Healthcare Payers And Providers, Medical Technology Companies, Regulatory And Health Technology Assessment Bodies, Contract Research Organizations And Academic Research Institutions
Subsegments:
1) By Services: Consulting Services, Regulatory Services Or Support, Data Management Services Or Data Integration
2) By Software: RWE Platforms And Dashboards, Predictive Modeling Or Analytics Tools
3) By Data Sets: Electronic Health Records, Patient Registries, Claims And Billing Data
What Market Trends Are Affecting The Pharmaceutical And Life Sciences Real World Evidence Market?
Major companies within the pharmaceutical and life sciences real-world evidence market are prioritizing the development of integrated data-driven platforms to enhance the effectiveness of clinical trials, improve patient participation, and facilitate regulatory and health economics submissions. These integrated platforms consolidate diverse real-world data sources, including patient-reported outcomes and data from wearable devices, into structured modules that streamline processes like recruitment, screening, enrollment, and continuous patient interaction. For instance, in September 2023, Maxis Clinical Sciences, a US-based boutique consulting firm, unveiled a comprehensive real-world evidence solution crafted to support patient-centric clinical research and drug development. This platform merges multiple data streams into pre-configured operational modules, thereby enabling faster trial execution while assisting with regulatory approvals, health economics and outcomes research (HEOR), and drug repurposing strategies.
Which Players Are Part Of The Competitive Landscape Of The Pharmaceutical And Life Sciences Real World Evidence Market?
Major companies operating in the pharmaceutical and life sciences real world evidence market are UnitedHealth Group Incorporated, Oracle Corporation, IQVIA Holdings Inc., ICON plc, Parexel International Corporation, Cegedim SA, Veradigm Inc., Tempus AI Inc., Saama Technologies LLC, Komodo Health Inc., Owkin Inc., Trinity Life Sciences LLC, TriNetX LLC, OM1 Inc., HealthVerity Inc., Claritas Rx Inc., PurpleLab Inc., Atropos Health PBC, EvidentIQ Group GmbH, CuriMeta Inc., Medaffcon Oy, and Mahalo Health Inc.
Get The Full Pharmaceutical And Life Sciences Real World Evidence Market Report:
Which Region Is The Top Contributor To The Pharmaceutical And Life Sciences Real World Evidence Market By Share?
North America was the largest region in the pharmaceutical and life sciences real world evidence market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical and life sciences real world evidence market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Pharmaceutical And Life Sciences Real World Evidence Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Pharmaceutical And Life Sciences Real World Evidence Market 2026, By The Business Research Company
adeno-associated virus (avv) vectors in gene therapy market report 2026
gastric cancer therapy market report 2026
https://www.thebusinessresearchcompany.com/report/gastric-cancer-therapy-global-market-report
over the counter (otc) drugs market report 2026
https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model